3.8 Letter

Treatment of Multiple Myeloma in Akita: Features and Outcomes in the Era of Novel Agents

Journal

Publisher

JAPANESE SOC LYMPHORETICULAR TISSUE RESEARCH
DOI: 10.3960/jslrt.54.89

Keywords

multiple myeloma; survival; bortezomib; lenalidomide; risk factors

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available